BSECompany Update2d ago · 23 Oct 2026, 05:22 pm

Schedule of Earnings Conference Call on Unaudited Financial Results for quarter ended September 30, 2026.

Rainbow Children's Medicare Ltd · 543524

✦ AI SummaryResults

Rainbow Children's Medicare Ltd has announced a schedule for an earnings conference call to discuss its unaudited financial results for the quarter ended September 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Rainbow Children's Medicare Ltd - 543524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Attachments (1)

📄

d9a8f93d-3925-44fd-8b7a-e84a139b656b.pdf

pdf

Download →
View document text
October 23, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, Plot No. C/1, G Block, Corporate Relationship Department, Bandra Kurla Complex, Bandra (E), Phiroze Jeejeebhoy Towers, Mumbai – 400 051. Dalal Street, Mumbai – 400001. Symbol: RAINBOW Scrip Code: 543524 Sub: Intimation of Earnings Conference Call – Q2 & FY 2026-27. Dear Sir/ Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015, please find attached invite of the Earnings Conference Call for Investors/ Analysts to be held on Monday, November 2, 2026 at 10:00 AM (IST) to discuss the financial and operating performance for quarter ended September 30, 2026. We request you to kindly take the same on record. Thanking You, Yours Faithfully, For Rainbow Children’s Medicare Limited Shreya Mitra Company Secretary and Compliance Officer Encl.: As above Rainbow Children’s Medicare Ltd Earnings Conference Call Monday, 02nd Nov 2026, 10:00 am (IST) IIFL is pleased to invite you to join a conference call with the management of Rainbow Children’s Medicare Ltd (RAINBOW IN) to discuss the company’s business strategy and outlook post the declaration of its Q2FY27 financial results. Dr. Ramesh Kancharla – Chairman and MD Mr. Abrar Ali Dalal – Group Chief Executive Officer Management participants Mr. Sudarshan Patodia – Group Chief Financial Officer Mr. Saurabh Bhandari – Head IR & Business Intelligence Monday, 2nd Nov 2026, 10:00 am (IST) Date / Time (HK/Singapore – 12:30 pm, UK – 4:30 am, USA – 11:30 pm ET – 1st Nov) Conference dial-in numbers Pre-registration link Diamond Pass Registration India Primary Number +91 22 6280 1259 / +91 22 7115 8160 International Toll-free number USA 1-866 746 2133 UK 0-808 101 1573 Singapore 800-101 2045 Hong Kong 800-964 448 For further information, please contact: Rahul Jeewani | Tel: +91 22 4646 4673 | Email: rahul.jeewani@iiflcap.com Naman Bagrecha | Tel: +91 22 4646 4718 | Email: naman.bagrecha@iiflcap.com Aman Goyal | Tel: +91 22 4646 4705 | Email: aman.goyal@iiflcap.com Vighnesh Indure | Tel: +91 22 4646 4661 | Email: vighnesh.indure@iiflcap.com IIFL - 24th floor, One Lodha Place, Senapati Bapat Marg, Lower Parel (W), Mumbai 400 013, Tel: (91-22) 4646 4600, Fax: (91-22) 4646 4700